Freestone Grove Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
+15,933
New +$1.05M 0.01% 535
2025
Q4
Sell
-867,709
Closed -$65.2M 806
2025
Q3
$65.2M Buy
867,709
+17,557
+2% +$1.31M 0.49% 54
2025
Q2
$63M Buy
850,152
+104,313
+14% +$7.26M 0.48% 60
2025
Q1
$60.2M Buy
+745,839
New +$64.1M 0.62% 39

Other funds holding GEHC

Freestone Grove Partners's GEHC Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in GE HealthCare (GEHC) in Q2 2026: 15,933 shares worth $1.02M. The stake represents 0.01% of the portfolio and ranks #535 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in GEHC as recently as Q3 2025.

Freestone Grove Partners first reported a position in GEHC in Q1 2025 and has held it in 4 quarters since. The position peaked at $65.2M in Q3 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Freestone Grove Partners held 15,933 shares of GE HealthCare worth $1.02M as of Q2 2026.
  • GE HealthCare was a new Freestone Grove Partners position in Q2 2026.
  • GE HealthCare made up 0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #535 holding.
  • Freestone Grove Partners first reported a position in GE HealthCare in Q1 2025 and has held it in 4 quarters since.
  • Freestone Grove Partners's GE HealthCare position peaked at $65.2M in Q3 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.